Author Information
Manuel Rosa-Calatrava is associated with the VirPath Team at the Laboratoire Virologie et Pathologie Humaine. He conducts research at the International Center for Infectious Diseases Research, a collaboration involving Inserm U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, and Université de Lyon, Faculté de Médecine RTH Laennec, Lyon, France. His work primarily focuses on virology and human pathology, contributing to the understanding and treatment of infectious diseases.Research Contributions
Manuel Rosa-Calatrava has made significant contributions to the field of infectious diseases, particularly in the context of SARS-CoV-2 and COVID-19. His research encompasses the development of therapeutic strategies, understanding viral interactions with host cells, and vaccine development. Notable studies include investigating the combined effects of Molnupiravir with other repurposed drugs against SARS-CoV-2, exploring the impact of Pseudomonas aeruginosa on SARS-CoV-2 infectivity, and analyzing early immune responses compromised by autoantibodies. His work extends to the evaluation of COVID-19 symptoms and the potential antiviral applications of existing drugs like Naproxen.Aliases
Manuel Rosa-Calatrava is also known by several aliases, including M Rosa-calatrava, M. Rosa-calatrava, and Manuel Rosa–calatrava. These variations may appear in different publications and databases.Publication and Citation Metrics
| Total Papers |
128 |
| Total Citations |
3605 |
| H-index |
34 |
